The Cooper Companies, Inc.

COO Healthcare Medical Instruments & Supplies

The Cooper Companies, Inc.’s revenue for fiscal 2025 (year ended October 2025) was $4.1 billion, up 5.06% from fiscal 2024. In the quarter to July 2026, revenue was flat, EPS grew 357.1%, free cash flow grew 66.0% and total debt rose 2.66%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for ten consecutive years, revenue growth for five; insiders bought in the last twelve months.

57.94 0.54 +0.94%
Market cap
$10.9B
P/E
19.8×
Fwd P/E
28.7×
Dividend yield
—
F-score
5/9
Altman Z
3.48
Beneish M
−2.50
Dividend safety
n/a
Older periods Oct '25 Jan '26 Apr '26 Jul '26
Piotroski F-Score

+8 more TTM periods

5 6 6 7
ROE
4.59% 4.87% 2.85% 6.84%
ROA
3.03% 3.26% 1.89% 4.55%
ROIC
4.01% 4.15% 2.95% 3.17%
Return on Tangible Assets
12.19% 15.12% 8.97% 22.28%
Average Days of Receivables
73.94 70.96 69.81 67.96
Free Cash Flow per Share
2.18 2.51 2.92 3.51
Free Cash Flow
433.70 491.20 569.50 678.00
Other line items

Show all line items

Columns are period end dates